These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13800797)

  • 1. A guinea pig potency test for adenovirus vaccine.
    BINN LN; HILLEMAN MR
    J Immunol; 1960 Jan; 84():20-6. PubMed ID: 13800797
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant influenza adenovirus vaccine.
    MEIKLEJOHN G
    JAMA; 1962 Feb; 179():594-7. PubMed ID: 14472203
    [No Abstract]   [Full Text] [Related]  

  • 3. A long-term study of antibody response to an adenovirus vaccine and observations on the effect of concurrent adenovirus disease.
    CULVER JO; LENNETTE EH; FOX VL; FLINTJER JD
    Am J Hyg; 1959 Jan; 69(1):38-48. PubMed ID: 13626943
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of and indications for use of adenovirus vaccine.
    HILLEMAN MR
    Am J Public Health Nations Health; 1958 Feb; 48(2):153-8. PubMed ID: 13521062
    [No Abstract]   [Full Text] [Related]  

  • 5. [Results of immunization of volunteers with live attenuated adenovirus vaccine type IV, V and VII. (Preliminary communication)].
    SMORODINTSEV AA; SELIVANOV AA
    Vopr Virusol; 1959; 4():648-52. PubMed ID: 13832219
    [No Abstract]   [Full Text] [Related]  

  • 6. An adenovirus vaccine potency test.
    TINT H; STONE J
    J Immunol; 1961 Mar; 86():253-6. PubMed ID: 13776999
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of an adenovirus vaccine in a dispensary population.
    STALLONES RA; LENNETTE EH; NITZ RE; HOLGUIN AH
    Am J Hyg; 1960 Jul; 72():100-10. PubMed ID: 13833681
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of adenovirus vaccine in Royal Air Force recruits.
    WILSON JS; GRANT PJ; MILLER DL; TAYLOR CE; McDONALD JC
    Br Med J; 1960 Apr; 1(5179):1081-3. PubMed ID: 13845090
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies of the significance of the recall phenomenon in the antibody response to adenovirus vaccine and infection.
    van der VEEN ; PRINS A
    J Immunol; 1960 Jun; 84():562-8. PubMed ID: 13841541
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of adenovirus vaccine in children with repeated acute respiratory illnesses.
    KOZINN PJ; WIENER H; BURCHALL JJ
    J Pediatr; 1961 Nov; 59():669-73. PubMed ID: 14459097
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection and infection rates in influenza and adenovirus vaccine evaluations.
    STILLE WT
    Am J Hyg; 1960 Mar; 71():129-33. PubMed ID: 13834680
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenovirus vaccine evaluation study in naval recruits.
    LOOSLI CG; TIPTON VC; WARNER O; SMITH M; JOHNSTON PB; HAMRE D
    Proc Soc Exp Biol Med; 1958 Jul; 98(3):583-9. PubMed ID: 13567779
    [No Abstract]   [Full Text] [Related]  

  • 13. Adenovirus vaccine: evaluation of antibody response and protective efficacy and comparison with an earlier preparation.
    LENNETTE EH; FLINTJER JD; CULVER JO; FOX VL; STEVENS TE
    Am J Hyg; 1960 Mar; 71():193-203. PubMed ID: 14415712
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of adenovirus vaccine on acute respiratory disease in U. S. Army recruits.
    SHERWOOD RW; BUESCHER EL; NITZ RE; COOCH JW
    JAMA; 1961 Dec; 178():1125-7. PubMed ID: 13911749
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody titer in allergic children given adenovirus vaccine.
    CHOBOT R; GOLDZIER SE; SCHWARTZ T; OSBORNE D
    J Allergy; 1959; 30(2):97-102. PubMed ID: 13630640
    [No Abstract]   [Full Text] [Related]  

  • 16. Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of Navy recruits. (Part I).
    SCHULTZ I; STILLE WT; GUNDELFINGER BF; MILLER LF
    Am J Public Health Nations Health; 1960 Apr; 50(4):543-50. PubMed ID: 14443778
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute respiratory infections in civilian adults. I. Antibody response to polyvalent influenza--adenovirus inactivated vaccine.
    COX F; TIMM EA; QUINN EL; COLVILLE JM; McLEAN IW
    Henry Ford Hosp Med Bull; 1962 Mar; 10():27-33. PubMed ID: 13881896
    [No Abstract]   [Full Text] [Related]  

  • 18. TESTING THE EFFECTIVENESS OF LIVE ADENOVIRUS VACCINE. I. REACTOGENIC PROPERTIES.
    SELIVANOV AA; PLESHANOVA RA; SKRYABINA EA; SMORODINTSEV AA
    Acta Virol; 1964 May; 8():263-70. PubMed ID: 14173474
    [No Abstract]   [Full Text] [Related]  

  • 19. TESTING THE EFFECTIVENESS OF LIVE ADENOVIRUS VACCINE. II. IMMUNOGENIC PROPERTIES.
    SELIVANOV AA; PLESHANOVA RA; SMORODINTSEV AA
    Acta Virol; 1964 May; 8():271-6. PubMed ID: 14173475
    [No Abstract]   [Full Text] [Related]  

  • 20. Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine.
    HILLEMAN MR; GREENBERG JH; WARFIELD MS; ANDERSON SA; GLABERE RR
    AMA Arch Intern Med; 1958 Sep; 102(3):428-36. PubMed ID: 13570730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.